RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 100-110
  • WHO's misplaced Ebola priority

    The World Health Organization is nothing if not opportunistic, impulsively jumping on every public health issue that makes the front page. And, of course, it always calls for lots more money to throw at the disease-of-the-month. The latest onĀ  WHO's radar...
  • Baxter reports success in late-stage trial on extended release hemophilia drug

    Baxter reports success in late-stage trial on extended release hemophilia drug
    Baxter International Inc. said Thursday a key hemophilia drug under development met its primary goal in a late-stage clinical study. The drug, known as BAX 855, is essentially a stronger, extended-release version of its flagship hemophilia drug Advate,...
  • Consumer Reports: 'Natural' foods with a catch

    You see the word "natural" on a food label, and you assume it means that there's nothing artificial in it, right? So you figure that it must be healthier for you. Maybe, but maybe not, warns ShopSmart, the shopping magazine from the publisher of Consumer...
  • Trader Joe's, Whole Foods nut butters recalled for risk of salmonella

    Trader Joe's, Whole Foods nut butters recalled for risk of salmonella
    Some almond butters sold at Trader Joe's and Whole Foods stores are being recalled due to possible contamination with salmonella. The almond butters are part of a larger nut butter recall also involving peanut butters, according to the U.S. Food and...
  • More defense in the asthma war

     
    With the summer weather so unbelievably pleasant in the Lehigh Valley in recent weeks, it's been easy to forget how difficult it is for some folks to breathe around here. The good news for them is that they just got new help in their war against asthma....
  • Review: 'Sweetness #9' by Stephan Eirik Clark

    Review: 'Sweetness #9' by Stephan Eirik Clark
    Time will tell if the literary equivalent of the lightning strike that catapulted Edan Lepucki's "California" to best-sellerdom will work its magic on Stephan Eirik Clark's debut novel as well. Lepucki got the coveted "Colbert Bump" in July when...
  • Doctors need marijuana training [Letter]

    Doctors need marijuana training [Letter]
    I would like to share my organization's thoughts with regard to recent discussions about medical marijuana in Maryland and the question of whether physicians should receive additional training ("Medical pot rules raise concern," July 26). As a statewide...
  • InterMune drug may offer big upside to Roche if aimed at liver

    (Reuters) - Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its...
  • E-cigarettes may be tempting non-smoking youths to smoke: CDC study

    E-cigarettes may be tempting non-smoking youths to smoke: CDC study
    Electronic cigarettes may be more tempting to non-smoking youths than conventional cigarettes, and once young people have tried e-cigarettes they are more inclined to give regular cigarettes a try, U.S. researchers said on Monday. A report, released by a...
  • Lawyers, not doctors, push medical pot: My Word

    This November, Florida voters will decide the fate of Amendment 2, which would allow marijuana to be recommended for medical purposes. If passed, this amendment would be enshrined in the state's constitution, and essentially, Florida could not turn back....
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...